Singapore Nervotec Launches AI Health Sensor for ChatGPT and Claude

Nervotec, a Singapore-based health AI company, has launched NervoScan MCP — a contactless biosensing tool that lets AI assistants like ChatGPT, Claude, and Gemini read a person's vital signs from a ten-second face scan using any standard laptop, phone, or webcam. The tool uses remote photoplethysmography (rPPG) to detect minute colour changes in facial video and outputs heart rate, heart rate variability, blood oxygen, respiratory rate, blood pressure, and a stress score.

What makes NervoScan MCP different from existing health tools in the AI ecosystem is that it is an active sensor rather than a passive reader. Every other health MCP integration so far reads data that a wearable or device has already captured. NervoScan MCP takes a fresh physiological reading on demand, giving AI assistants real-time awareness of the person using them. The technology was developed in collaboration with Singapore General Hospital and has peer-reviewed results published in JMIR Formative Research.

The launch arrives as agentic AI assistants become more embedded in daily workflows — planning schedules, managing communications, and making decisions. Adding a physiological signal layer means an AI assistant could factor in a user's stress level or heart rate before recommending a break, adjusting a workout, or routing a health-related query. Nervotec founder Jonathan Lau describes it as giving AI "the ability to sense, not just reason."

Why it matters for Singapore: Nervotec is a homegrown deep-tech company built on research done with Singapore's public healthcare system. The launch positions Singapore as a source of proprietary AI health-sensing technology rather than just a market for imported AI tools. As MCP becomes a standard way for AI models to interface with the physical world, a Singapore company owning a validated biosensing layer creates a differentiating asset in the global AI tooling ecosystem.